---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-112658"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2024-12-26T23:59:59+00:00"
generated_at: "2026-05-28T23:12:38.009945+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# China Pharma shareholders approve reverse stock split at 1:10–1:20; all directors elected

## Summary
- All five director nominees elected: Zhilin Li, Heung Mei Tsui (non-independent), Gene Michael Bennett, Yingwen Zhang, Baowen Dong (independent).
- Amendment to allow reverse stock split at ratio between 1:10 and 1:20 approved; board retains discretion to effect.
- Amendment No.2 to the 2010 Long-Term Incentive Plan approved by shareholders.
- Advisory vote on executive compensation approved; frequency set at every three years.
- Annual meeting held Dec 22, 2024; quorum of ~52% (9,688,133 shares) of outstanding stock.

## SEC filing metadata
- accession: 0001213900-24-112658
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2024-12-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390024112658/0001213900-24-112658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390024112658/ea022580301-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-112658
- JSON: https://secwatch.observer/filing/0001213900-24-112658.json
- Plain text: https://secwatch.observer/filing/0001213900-24-112658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.